SCI 발표논문

SCI 발표논문

← SCI 발표논문 목록

Nat Med. 2026;32(7):2410-2419.

Electronic cigarette use after smoking cessation and lung cancer risk.

, , , , , , , , ,

제1저자 김연욱 · 교신저자 김연욱

소속 (7)
  1. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea. kimyw@snu.ac.kr.
  2. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea. kimyw@snu.ac.kr.
  3. Big Data Center, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
  4. Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, Republic of Korea.
  5. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
  6. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  7. Seoul National University College of Medicine, Seoul, Republic of Korea.

Abstract

Electronic cigarettes (e-cigarettes) have gained popularity as a less harmful alternative to conventional cigarettes, yet their associations with lung cancer risk after smoking cessation remain uncertain. Here we evaluated 4,524,895 adults with a conventional smoking history who participated in the Korean National Health Screening Program in 2018 (baseline), with prior records from 2012-2014. Participants were classified as current smokers, short-term quitters or long-term quitters, and followed up to December 2023. Daily e-cigarette use at baseline was used to define post-cessation e-cigarette use. Lung cancer incidence and lung cancer-specific death (LCSD) were assessed using multivariable Cox models. Over 24,182,543 person-years, 35,887 lung cancers and 12,807 LCSD events occurred. Compared with complete quitters, e-cigarette use after smoking cessation was associated with higher risks of lung cancer incidence (adjusted hazard ratio (aHR) 1.56, 95% confidence interval (CI) 1.24-1.97) and LCSD (aHR 2.00, 95% CI 1.28-3.15). Associations were directionally consistent in short-term and long-term quitters and were prominent in the high-risk subgroup (incidence: aHR 1.91, 95% CI 1.44-2.53; LCSD: aHR 1.92, 95% CI 1.13-3.24). Although causality cannot be established, these findings suggest that e-cigarette use after smoking cessation may attenuate the benefits of complete cessation for lung cancer prevention.

© 2026. The Author(s), under exclusive licence to Springer Nature America, Inc.

Conflict of interest statement

Competing interests: Y.W.K. has received honorarium from AstraZeneca, and research grants not related to this study from AstraZeneca. The other authors declare no competing interests.

그 밖의 정보
출판 형태
Journal Article
저널
Nature medicine · eISSN 1546-170X
전자 출판
2026-06-08
MeSH
Humans · Lung Neoplasms* / epidemiology / etiology / mortality · Smoking Cessation* · Female · Electronic Nicotine Delivery Systems* · Middle Aged · Male · Republic of Korea / epidemiology · Incidence · Risk Factors · Adult · Vaping* / adverse effects / epidemiology · Proportional Hazards Models · Aged
참고문헌
55편